Inevitably we see cases in underwriting where the applicant has had an abnormality in a screening test and the follow-up testing is in progress or has been inconclusive. Those individuals are often postponed, while other applicants with similar characteristics who are not undergoing screening tests sail through the underwriting process without a second thought.
Understanding the association between persistent cervical infection with high-risk human papillomavirus (HPV) and the development of cervical cancer is fundamental when underwriting cases where HPV is present. This article explores the latest research and relationship.
The latest issue of RGA’s global medical newsletter includes the following articles:
- Critical Illness Insurance: A Medical Perspective
- Cervical Cancer Update
- Longer Life Foundation
- ReCite: Interesting and relevant articles in insurance medicine
- Recent Webcasts